This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chenoweth, M. R.
Right arrow Articles by Gherardini, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chenoweth, M. R.
Right arrow Articles by Gherardini, F. C.

 Previous Article  |  Next Article 

Infection and Immunity, June 2004, p. 3097-3105, Vol. 72, No. 6
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.6.3097-3105.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Predominant Outer Membrane Antigens of Bartonella henselae

Matthew R. Chenoweth,1,2 Craig E. Greene,3 Duncan C. Krause,1 and Frank C. Gherardini2*

Department of Microbiology,1 Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602,3 Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 598402

Received 6 January 2004/ Returned for modification 13 February 2004/ Accepted 2 March 2004

A hallmark of Bartonella henselae is persistent bacteremia in cats despite the presence of a vigorous host immune response. To understand better the long-term survival of B. henselae in cats, we examined the feline humoral immune response to B. henselae outer membrane (OM) proteins in naturally and experimentally infected cats. Initially, a panel of sera (n = 42) collected throughout North America from naturally infected cats was used to probe B. henselae total membranes to detect commonly recognized antigens. Twelve antigens reacted with sera from at least 85% of cats, and five were recognized by sera from all cats. To localize these antigens further, OMs were purified on discontinuous sucrose density step gradients. Each membrane fraction (OM, hybrid or inner membrane [IM]) contained less than 1% of the total malate dehydrogenase activity (soluble marker), indicating very little contamination by cytoplasmic proteins. FtsI, an integral IM cell division protein, was used to identify the low-density fraction ({rho} = 1.13 g/cm3) as putative IM (<5% of the total FtsI localized to the high-density fraction) while lipopolysaccharide (LPS) and Pap31, a homolog of the Bartonella quintana heme-binding protein A (HbpA), defined the high-density fraction ({rho} = 1.20 g/cm3) as putative OM. Additionally, little evidence of cross-contamination between the IM and OM was evident by two-dimensional gel electrophoresis. When purified OMs were probed with feline sera, antigenic proteins profiles were very similar to those observed with total membranes, indicating that many, but not all, of the immunoreactive proteins detected in the initial immunoblots were OM components. Interestingly, two-dimensional immunoblots indicated that B. henselae LPS and members of the Hbp family of proteins did not appear to stimulate an humoral response in any infected cats. Seven proteins were recognized by at least 70% of sera tested, but only three were recognized by all sera. Nanospray-tandem mass spectrometry was used to identify OM components, including the immunodominant OM proteins. Recognition of the nonimmunogenic nature of the major OM components, such as LPS, and identification of the predominant immunogens should elucidate the mechanisms by which B. henselae establishes persistent bacteremic infections within cats. Additionally, the common antigens may serve as potential feline vaccine candidates to eliminate the pathogen from its animal reservoir.


* Corresponding author. Mailing address: Rocky Mountain Laboratories, 903 S. 4th St., Hamilton, MT 59840. Phone: (406) 363-9474. Fax: (406) 363-9478. E-mail: FGHERARDINI{at}NIAID.NIH.GOV.

Editor: J. B. Bliska


Infection and Immunity, June 2004, p. 3097-3105, Vol. 72, No. 6
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.6.3097-3105.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Litwin, C. M., Rawlins, M. L., Swenson, E. M. (2007). Characterization of an Immunogenic Outer Membrane Autotransporter Protein, Arp, of Bartonella henselae. Infect. Immun. 75: 5255-5263 [Abstract] [Full Text]  
  • Hagan, E. C., Mobley, H. L. T. (2007). Uropathogenic Escherichia coli Outer Membrane Antigens Expressed during Urinary Tract Infection. Infect. Immun. 75: 3941-3949 [Abstract] [Full Text]  
  • Berghoff, J., Viezens, J., Guptill, L., Fabbi, M., Arvand, M. (2007). Bartonella henselae exists as a mosaic of different genetic variants in the infected host. Microbiology 153: 2045-2051 [Abstract] [Full Text]  
  • Boonjakuakul, J. K., Gerns, H. L., Chen, Y.-T., Hicks, L. D., Minnick, M. F., Dixon, S. E., Hall, S. C., Koehler, J. E. (2007). Proteomic and Immunoblot Analyses of Bartonella quintana Total Membrane Proteins Identify Antigens Recognized by Sera from Infected Patients. Infect. Immun. 75: 2548-2561 [Abstract] [Full Text]  
  • Werner, J. A., Feng, S., Kasten, R. W., Hodzic, E., Chomel, B. B., Barthold, S. W. (2006). Cloning, Characterization, and Expression of Bartonella henselae p26.. CVI 13: 830-836 [Abstract] [Full Text]  
  • Dabo, S. M., Confer, A. W., Anderson, B. E., Gupta, S. (2006). Bartonella henselae Pap31, an Extracellular Matrix Adhesin, Binds the Fibronectin Repeat III13 Module.. Infect. Immun. 74: 2513-2521 [Abstract] [Full Text]